Stock News

UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs

As seen on...